Ridgecrest Wealth Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Buy
2,164
+1
+0% +$115 0.12% 87
2026
Q1
$259K Hold
2,163
0.14% 81
2025
Q4
$295K Buy
2,163
+1
+0% +$144 0.16% 79
2025
Q3
$319K Hold
2,162
0.14% 82
2025
Q2
$280K Buy
2,162
+1
+0% +$121 0.15% 87
2025
Q1
$258K Buy
2,161
+172
+9% +$21.3K 0.14% 94
2024
Q4
$231K Sell
1,989
-31
-2% -$3.92K 0.13% 94
2024
Q3
$273K Buy
2,020
+503
+33% +$67.3K 0.14% 90
2024
Q2
$206K Buy
+1,517
New +$206K 0.12% 98
2023
Q3
Sell
-1,800
Closed -$203K 104
2023
Q2
$203K Buy
+1,800
New +$190K 0.13% 98
2022
Q1
Sell
-1,820
Closed -$218K 124
2021
Q4
$218K Hold
1,820
0.11% 111
2021
Q3
$225K Hold
1,820
0.12% 105
2021
Q2
$218K Buy
+1,820
New +$208K 0.14% 99

Other funds holding XYL

Ridgecrest Wealth Partners's XYL Position: Q2 2026 in Review

Ridgecrest Wealth Partners increased its Xylem (XYL) stake by 0.05% in Q2 2026, buying an estimated $115 and bringing the position to 2,164 shares worth $256K. The position accounts for 0.12% of the portfolio, ranked #87.

Ridgecrest Wealth Partners first reported a position in XYL in Q2 2021 and has held it in 13 quarters since. The position peaked at $319K in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Ridgecrest Wealth Partners held 2,164 shares of Xylem worth $256K as of Q2 2026.
  • Ridgecrest Wealth Partners bought 1 Xylem share in Q2 2026, an estimated $115.
  • Xylem made up 0.12% of Ridgecrest Wealth Partners's portfolio in Q2 2026, its #87 holding.
  • Ridgecrest Wealth Partners first reported a position in Xylem in Q2 2021 and has held it in 13 quarters since.
  • Ridgecrest Wealth Partners's Xylem position peaked at $319K in Q3 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Ridgecrest Wealth Partners's 13F filing for Q2 2026, filed 5 Aug 2026.